enGene Holdings share price logo

enGene Holdings

NASDAQ: ENGN

$1.87

+0.07

(+3.89%)

as on

enGene Holdings Stock Performance

as on September 15, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $1.80
    $1.88
    downward going graph

    3.74%

    Downside

    0.53%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.40
    $12.25
    downward going graph

    25.13%

    Downside

    555.08%

    Upside

    downward going graph

enGene Holdings share price movements today

Previous Close
$1.80
Open
$1.81
Volume
772.9K
Market Cap
$120.6M
Day's Low - High
$1.80 - $1.88
52 Week Low - High
$1.40 - $12.25

enGene Holdings Historical Returns

1 Month Return
+ 10 %
3 Month Return
+ 5.65 %
1 Year Return
-68.68 %
3 Year Return
0 %
5 Year Return
0 %

enGene Holdings Stock Fundamentals & Key Indicators

Check enGene Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$120.6M

EPS (TTM)

-0.28

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-6.43

Industry PE ratio

-4.62

PEG Ratio

-0.062212908908906836

EBITDA

-131.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-2.10%

enGene Holdings Stock Valuation

Track how enGene Holdings P/E has moved over time to understand its valuation trends.

enGene Holdings in the last 5 years

  • Overview

  • Trends

Lowest (-13.49x)

October 31, 2021

Industry (-4.62x)

October 31, 2025

Today (-3.15x)

October 31, 2025

Highest (10292.91x)

October 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -3.15x

enGene Holdings vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of enGene Holdings with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$120.6MNA-6.430.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$130.6B175.08%29.7686.04%NA
BUY$57.5B-66.24%-18.04-12.57%NA
BUY$80.5B21.74%18.9584.86%47.339999999999996%

Stock Returns calculator for enGene Holdings Stock including INR - Dollar returns

The enGene Holdings stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

enGene Holdings investment value today

Current value as on today

₹33,960

Returns

-₹66,040

(-66.04%)

Returns from enGene Holdings Stock

-₹68,677 (-68.68%)

Dollar Impact

₹2,637 (+2.64%)

Analyst Recommendation on enGene Holdings Stock

Based on 5 analysts

BUY

20.00%

Buy

60.00%

Hold

20.00%

Sell

Based on 5 analysts, 60% of analysts recommend a 'BUY' rating for enGene Holdings. Average target price of $3.29

enGene Holdings Share Price Target

Get share price movements and forecasts by analysts on enGene Holdings.

What analysts predicted

43.16%UPSIDE

Target Price

$3.29

Current Price

$1.87

Analyzed by

5 Analysts

Target

$3.29

enGene Holdings target price $3.29, a slight upside of 43.16% compared to current price of $1.87. According to 5 analysts rating.

Indian Investors' Interest in enGene Holdings Stock

Search interest for enGene Holdings Stock has increased by 79% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:79% versus previous 30 day period

enGene Holdings Quarterly Profit & Loss

All numbers in Millions USD

Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
-
-
-
-
-
-
0
0
0
Operating Income
-17
-16
-17
-26
-27
-29
-39
-31
31
34
EBITDA
-14
-13
-14
-23
-24
-27
-37
-28
-31
-33
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-14
-14
-15
-24
-25
-28
-38
-29
30
32
Income Tax Expense
0
0
0
0
0
0
0
-
-
-
Net Income
-14
-14
-15
-24
-25
-28
-37
-29
30
32
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

enGene Holdings Annual Profit & Loss

All numbers in Millions USD

Oct 2021
Oct 2022
Oct 2023
Oct 2024
Oct 2025
Total Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Income
-15
-19
-26
-62
-123
EBITDA
-18
-22
-94
-52
-113
Interest Expense
5
1
4
2
2
Depreciation
0
0
0
0
0
Income Before Tax
-23
-24
-99
-55
-117
Income Tax Expense
-
0
0
0
-
Net Income
-23
-24
-99
-55
-117
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

enGene Holdings Quarterly Cash Flow

All numbers in Millions USD

Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Net Income
-14
-14
-15
-24
-25
-28
-37
-29
-30
-32
Operating Cash Flow
-14
-7
-19
-25
-22
-25
-24
-28
-30
-18
Investing Cash Flow
0
0
-125
-84
17
1
40
-126
23
30
Financing Cash Flow
193
0
60
0
0
0
1
141
0
0
Change in Cash
179
-7
-84
-110
-4
-24
17
-13
-6
11

enGene Holdings Annual Cash Flow

All numbers in Millions USD

Oct 2021
Oct 2022
Oct 2023
Oct 2024
Oct 2025
Net Income
-23
-24
-99
-55
-117
Operating Cash Flow
-15
-17
-24
-48
-99
Investing Cash Flow
0
0
0
-125
-25
Financing Cash Flow
22
27
86
265
1
Change in Cash
6
9
61
91
-122

Mutual Funds that own enGene Holdings Stock

Check out the Mutual Funds with significant holdings in enGene Holdings.

Funds
Holdings
Shares Held
Franklin Strategic Series
0.72606%
486579

Global Institutional Holdings in enGene Holdings

Funds
Holdings
Joseph Edelman
7.2%
Otello Stampacchia
1.31%
Michael Rockefeller
0.37%
Dimensional
0%

enGene Holdings News & Key Events

  • img

    Today's Timeline - 11 November

    Tue, 09:07 PM

    -

    enGene reports promising Phase 2 trial data, leading to a 64.73% stock increase.

Insights on enGene Holdings

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, ENGN stock has moved up by 10.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 514.3% return, outperforming this stock by 583.0%

About enGene Holdings

enGene Therapeutics Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. The company was formerly known as enGene Holdings Inc. and changed its name to enGene Therapeutics Inc. in April 2026. enGene Therapeutics Inc. is based in Montreal, Canada.
OrganisationenGene Holdings
Headquarters4868 Rue Levy, Montreal, QC, Canada, H4R 2P1
IndustryBiotechnology
CEOMr. Ronald H. W. Cooper
E-voting on sharesClick here to vote

Key Management of enGene Holdings

Name

Title

Ms. Jill Buck

Chief Development Officer

Ms. Amy Pott

Chief Global Commercialization Officer

Mr. Ronald H. W. Cooper

President, CEO & Director

Dr. William J. Grossman M.D., Ph.D.

Interim Chief Medical Officer & Director

Ms. Kathleen Richton

Senior VP of Finance, Principal Accounting & Financial Officer and Controller

Mr. Matthew Boyd

Chief Regulatory Officer

Dr. Anthony T. Cheung Ph.D.

Co-Founder & Chief Scientific Officer

Ms. Joan Connolly

Chief Technology Officer

Ms. Tara Place M.B.A.

Senior VP of Human Resources

FAQs

What is enGene Holdings share price today?

enGene Holdings share price today is $1.87 as on at the close of the market. enGene Holdings share today touched a day high of $1.88 and a low of $1.80.

What is the 52 week high and 52 week low for enGene Holdings share?

enGene Holdings share touched a 52 week high of $12.25 on and a 52 week low of $1.40 on . enGene Holdings stock price today i.e. is closed at $1.87,which is 84.73% down from its 52 week high and 33.57% up from its 52 week low.

What is enGene Holdings's market capitalisation today?

enGene Holdings market capitalisation is $0.00T as on .

How to invest in enGene Holdings Stock (ENGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for enGene Holdings on INDmoney app. Click on Buy button. You can invest as low as $1.5 in enGene Holdings Shares that will get you 0.8021 shares as per enGene Holdings share price of $1.87 per share as on September 15, 2026 at 8:45 am IST.

What is the minimum amount required to buy enGene Holdings Stock (ENGN) from India?

Indian investors can start investing in enGene Holdings (ENGN) shares with as little as ₹95.54 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in enGene Holdings stock (as per the Rupee-Dollar exchange rate as on ). Based on enGene Holdings share’s latest price of $1.87 as on September 15, 2026 at 8:45 am IST, you will get 5.3476 shares of enGene Holdings. Learn more about fractional shares .